A Study Of Eko Digital Auscultation For Structural Heart Murmur (FLEAT STUDY)

Overview

About this study

The purpose of this study is to decision-support (disease-association) performance of the FDA-cleared structural-murmur output with prespecified transthoracic echocardiography (TTE)-defined native structural heart disease composites in adults (labeling-concordant; not stand-alone diagnostic claims).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age 18 years and older.
Undergoing a clinically indicated transthoracic echocardiogram,
Ability to provide informed consent

Exclusion Criteria:

Prior enrollment in this study.
Skin condition, wound, dressings, or isolation limitation that prevents safe or practical placement of the stethoscope.
Complex congenital heart disease
Ventricular Assist Device

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 05/11/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Garvan Kane, M.D., Ph.D.	Open for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Garvan Kane, M.D., Ph.D.

Open for enrollment

More information

Publications

Publications are currently not available

Clinical Trials